跳至主要内容
临床试验/EUCTR2011-005456-33-AT
EUCTR2011-005456-33-AT进行中(未招募)1 期

PREVENTING CHOLESTASIS IN PREMATURE INFANTS USING SMOFLIPID - Smoflipid

Med. Univ. Wien, Universitätsklinik für Kinder- und Jugendheilkunde0 个研究点目标入组 200 人开始时间: 2012年1月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Infants born with a birth weight = 1000 Gram (= extreme low birth weight infants)
  • Admission to the neonatal ward in the first 24 hours of life
  • Informed consent obtained and randomized on study drug the first 5 days of life
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 200
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Triplets or higher
  • Conjugated bilirubin > 1.5 mg/dl before inclusion to the study
  • Conditions associated with cholestasis independent of parenteral nutrition:
  • o Inborn errors of metabolism
  • o Viral Infections (cytomegaly virus, HIV, Hepatitis B, C)
  • o Immune mediated hemolytic diesease (e.g. Rhesus incompatibility)
  • o Cystic fibrosis
  • o Primary cholestatic diseases of the liver

研究者

发起方
Med. Univ. Wien, Universitätsklinik für Kinder- und Jugendheilkunde

相似试验